Kepos Capital LP Eagle Pharmaceuticals, Inc. Transaction History
Kepos Capital LP
- $121 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
11Shares Held
456KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY353KShares$694,9410.0% of portfolio
-
Ajo Vista, LLC Boston, MA56.4KShares$111,1820.92% of portfolio
-
Barclays PLC London, X014.2KShares$28,0390.0% of portfolio
-
Stanley Laman Group, Ltd. Berwyn, PA12KShares$23,6400.0% of portfolio
-
Hightower 6 M Holding, LLC8.86KShares$17,4580.02% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $25.6M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...